Daniel Cattran

11.7k total citations · 1 hit paper
84 papers, 5.7k citations indexed

About

Daniel Cattran is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Transplantation. According to data from OpenAlex, Daniel Cattran has authored 84 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Nephrology, 23 papers in Pulmonary and Respiratory Medicine and 17 papers in Transplantation. Recurrent topics in Daniel Cattran's work include Renal Diseases and Glomerulopathies (56 papers), Chronic Kidney Disease and Diabetes (33 papers) and Renal Transplantation Outcomes and Treatments (17 papers). Daniel Cattran is often cited by papers focused on Renal Diseases and Glomerulopathies (56 papers), Chronic Kidney Disease and Diabetes (33 papers) and Renal Transplantation Outcomes and Treatments (17 papers). Daniel Cattran collaborates with scholars based in Canada, United States and United Kingdom. Daniel Cattran's co-authors include Heather N. Reich, Jai Radhakrishnan, James W. Scholey, Fernando C. Fervenza, Celia M.T. Greenwood, Susan Ritchie, Carl J. Cardella, Edward Cole, York Pei and Ginette Lajoie and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Kidney International.

In The Last Decade

Daniel Cattran

80 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

2019 281 citations Sean J. Barbour, Rosanna Coppo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Cattran Canada	38	4.5k	1.5k	1.4k	859	644	84	5.7k
Heather N. Reich Canada	43	3.8k 0.8×	1.0k 0.7×	843 0.6×	796 0.9×	786 1.2×	143	5.9k
Stephen M. Korbet United States	44	4.6k 1.0×	821 0.5×	1.6k 1.1×	336 0.4×	968 1.5×	99	6.5k
James V. Donadío United States	34	2.5k 0.5×	710 0.5×	740 0.5×	519 0.6×	541 0.8×	75	4.0k
Richard Lafayette United States	33	2.2k 0.5×	432 0.3×	755 0.5×	536 0.6×	910 1.4×	156	4.5k
Franco Ferrario Italy	36	4.1k 0.9×	558 0.4×	3.0k 2.1×	440 0.5×	1.5k 2.4×	99	7.1k
Claudio Pozzi Italy	24	2.2k 0.5×	650 0.4×	637 0.4×	610 0.7×	721 1.1×	69	2.9k
Sonia Pasquali Italy	26	1.7k 0.4×	450 0.3×	673 0.5×	425 0.5×	713 1.1×	48	2.7k
Kenji Ishikura Japan	29	1.9k 0.4×	501 0.3×	409 0.3×	351 0.4×	634 1.0×	160	3.0k
Dwomoa Adu United Kingdom	30	1.3k 0.3×	302 0.2×	1.4k 1.0×	250 0.3×	509 0.8×	73	3.2k
Colin D. Short United Kingdom	27	1.2k 0.3×	354 0.2×	532 0.4×	223 0.3×	450 0.7×	65	2.4k

Countries citing papers authored by Daniel Cattran

Since Specialization

Citations

This map shows the geographic impact of Daniel Cattran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Cattran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Cattran more than expected).

Fields of papers citing papers by Daniel Cattran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Cattran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Cattran. The network helps show where Daniel Cattran may publish in the future.

Co-authorship network of co-authors of Daniel Cattran

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Cattran. A scholar is included among the top collaborators of Daniel Cattran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Cattran. Daniel Cattran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barbour, Sean J., Rosanna Coppo, Jonathan Barratt, et al.. (2025). Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts. Kidney International Reports. 10(7). 1283–1287.

Barratt, Jonathan, Adrian Liew, See Cheng Yeo, et al.. (2024). Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial. Clinical Journal of the American Society of Nephrology. 19(4). 452–462. 28 indexed citations

Barbour, Sean J., Fernando C. Fervenza, Paul Brenchley, et al.. (2023). Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy. Clinical Journal of the American Society of Nephrology. 18(10). 1283–1293. 21 indexed citations

Barbour, Sean, et al.. (2018). 15th International Symposium on IgANephropathy – IIgANN 2018, Buenos Aires, September 27-29, 2018: Summaries. Kidney Diseases. 4(3). 145–194. 1 indexed citations

Cattran, Daniel & Paul Brenchley. (2016). Membranous nephropathy: thinking through the therapeutic options. Nephrology Dialysis Transplantation. 32(suppl_1). i22–i29. 36 indexed citations

Thompson, Aliza, Daniel Cattran, Melanie Blank, & Patrick H. Nachman. (2015). Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy. Journal of the American Society of Nephrology. 26(12). 2930–2937. 69 indexed citations

Barbour, Sean J., Daniel Cattran, Gabriela Espino-Hernández, Michelle Hladunewich, & Heather N. Reich. (2015). Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis. Kidney International. 88(6). 1392–1401. 34 indexed citations

Lv, Jicheng, Sufang Shi, Damin Xu, et al.. (2013). Evaluation of the Oxford Classification of IgA Nephropathy: A Systematic Review and Meta-analysis. American Journal of Kidney Diseases. 62(5). 891–899. 126 indexed citations

Lee, Taewoo, Andrea K. Biddle, Sophia Lionaki, et al.. (2013). Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy. Kidney International. 85(6). 1412–1420. 69 indexed citations

10.

Radhakrishnan, Jai & Daniel Cattran. (2012). The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines—application to the individual patient. Kidney International. 82(8). 840–856. 295 indexed citations

11.

Beck, Laurence H., Fernando C. Fervenza, Ramon Bonegio, et al.. (2011). Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy. Journal of the American Society of Nephrology. 22(8). 1543–1550. 337 indexed citations

12.

Fervenza, Fernando C., Roshini S. Abraham, Stephen B. Erickson, et al.. (2010). Rituximab Therapy in Idiopathic Membranous Nephropathy. Clinical Journal of the American Society of Nephrology. 5(12). 2188–2198. 207 indexed citations

13.

Fervenza, Fernando C., Fernando G. Cosio, Stephen B. Erickson, et al.. (2008). Response to ‘Rituximab in membranous nephropathy’. Kidney International. 74(3). 392–392. 1 indexed citations

14.

Philibert, David, Daniel Cattran, & Terence Cook. (2008). Clinicopathologic Correlation in IgA Nephropathy. Seminars in Nephrology. 28(1). 10–17. 11 indexed citations

15.

Jeloka, Tarun, Heather J. Ross, Robert Smith, et al.. (2007). Renal transplant outcome in high‐cardiovascular risk recipients. Clinical Transplantation. 21(5). 609–614. 36 indexed citations

16.

Prasad, G. V. Ramesh, S. Joseph Kim, Michael Huang, et al.. (2004). Reduced Incidence of New-Onset Diabetes Mellitus after Renal Transplantation with 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors (Statins). American Journal of Transplantation. 4(11). 1897–1903. 43 indexed citations

17.

Cattran, Daniel. (2002). Membranous nephropathy: Quo vadis?. Kidney International. 61(1). 349–350. 28 indexed citations

18.

Pei, York, J. W. Scholey, K. Thai, Masataka Suzuki, & Daniel Cattran. (1997). Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients.. Journal of Clinical Investigation. 100(4). 814–820. 108 indexed citations

19.

Cattran, Daniel, York Pei, Celia M.T. Greenwood, et al.. (1997). Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications. Kidney International. 51(3). 901–907. 161 indexed citations

20.

Cattran, Daniel, Terry Delmore, Janet Roscoe, et al.. (1989). A Randomized Controlled Trial of Prednisone in Patients with Idiopathic Membranous Nephropathy. New England Journal of Medicine. 320(4). 210–215. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact